Palvella Therapeutics, Inc. (formerly Pieris Pharmaceuticals, Inc.) is a clinical-stage biopharmaceutical company focused on developing therapeutics for rare skin diseases and vascular malformation indications. Its lead programs include QTORIN rapamycin and QTORIN pitavastatin, along with research-stage opportunities. The company was formed via a merger between Pieris Pharmaceuticals and Legacy Palvella Therapeutics, consummated on December 13, 2024.
Q2 FY2026 — expected 2026-09-13
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-31 | 2025-12-31 | 0001193125-26-133372 | EDGAR | 104K words |
| 2025-03-31 | 2024-12-31 | 0000950170-25-047212 | EDGAR | 99K words |
| 2024-03-29 | 2023-12-31 | 0001437749-24-010123 | EDGAR | 81K words |
| 2023-03-31 | 2022-12-31 | 0001437749-23-008834 | EDGAR | — |
| 2022-03-02 | 2021-12-31 | 0001583648-22-000016 | EDGAR | — |
| 2021-03-31 | 2020-12-31 | 0001583648-21-000005 | EDGAR | — |
| 2020-03-13 | 2019-12-31 | 0001583648-20-000015 | EDGAR | — |
| 2019-03-18 | 2018-12-31 | 0001583648-19-000011 | EDGAR | — |
| 2018-03-15 | 2017-12-31 | 0001583648-18-000017 | EDGAR | — |
| 2017-03-30 | 2016-12-31 | 0001193125-17-102052 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-04 | 2026-06-30 | 0001193125-26-331574 | EDGAR | 26K words |
| 2025-11-12 | 2025-09-30 | 0001193125-25-276119 | EDGAR | 24K words |
| 2025-08-14 | 2025-06-30 | 0000950170-25-108438 | EDGAR | 23K words |
| 2025-05-15 | 2025-03-31 | 0000950170-25-071998 | EDGAR | 21K words |
| 2024-11-13 | 2024-09-30 | 0001437749-24-034891 | EDGAR | 29K words |
| 2024-08-14 | 2024-06-30 | 0001437749-24-026778 | EDGAR | 31K words |
| 2024-05-15 | 2024-03-31 | 0001437749-24-017037 | EDGAR | 66K words |
| 2023-11-14 | 2023-09-30 | 0001437749-23-031957 | EDGAR | 33K words |
| 2023-08-10 | 2023-06-30 | 0001437749-23-023085 | EDGAR | 33K words |
| 2023-05-11 | 2023-03-31 | 0001437749-23-013687 | EDGAR | 29K words |
| 2022-11-04 | 2022-09-30 | 0001437749-22-026023 | EDGAR | — |
| 2022-08-04 | 2022-06-30 | 0001583648-22-000065 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-04 | 0001193125-26-331556 | EDGAR | 3K words |
| 2026-07-14 | 0001193125-26-303307 | EDGAR | 6K words |
| 2026-03-31 | 0001193125-26-133332 | EDGAR | 3K words |
| 2026-02-26 | 0001104659-26-020667 | EDGAR | 26K words |
| 2026-02-24 | 0001104659-26-019143 | EDGAR | 1K words |
| 2026-02-24 | 0001193125-26-065308 | EDGAR | 2K words |
| 2026-02-24 | 0001193125-26-065159 | EDGAR | 2K words |
| 2026-01-29 | 0001193125-26-029341 | EDGAR | 5K words |
| 2026-01-12 | 0001193125-26-009724 | EDGAR | 5K words |
| 2025-12-15 | 0001104659-25-120789 | EDGAR | 2K words |
308 total filings indexed. 276 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001583648 |
| Ticker | PVLA |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | NV |
| Website | https://www.palvellatx.com |
| Listed | 2024-12-16 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/PVLA (~200 tokens, structured JSON with cryptographic provenance)